Kyle Diamantas, who was elevated to FDA acting commissioner earlier this week, is telling anti-abortion groups he asked to be taken off a case defending Planned Parenthood due to moral objections.
The temporary punt gives the justices more time to figure out how to handle competing arguments from Louisiana, the Trump administration, and drugmakers.